Skip to main content

Table 1 Patient characteristics at ICU admission

From: Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia

 

Subsequent VAP

P-value

 

Yes n = 17

No n = 105

 

Age, years

70 (60, 78)

64 (50, 75)

0.086

Male gender

10 (58)

68 (55)

0.786

SAPS II

54 (41, 59)

46 (35, 58)

0.307

SOFA score, mean ± SD

6.3 ± 3.2

6.4 ± 3.7

0.899

Admission category

  

0.999

  Medical

13 (76)

80 (76)

 

  Surgical

3 (17)

19 (18)

 

  Trauma

1 (5)

6 (5)

 

Comorbidities

   

  COPD

7 (4)

36 (34)

0.593

  Cirrhosis

1 (5)

3 (2)

0.456

  Chronic renal failure

1 (5)

8 (7)

>0.999

  Diabetes

4 (23)

17 (16)

0.491

  Chronic heart failure

2 (11)

19 (18)

0.734

  Immunosuppression

2 (11)

7 (6)

0.611

Cause of ICU admission

   

  Acute exacerbation of COPD

4 (23)

16 (15)

0.478

  ARDS

2 (11)

9 (8)

0.651

  Shock

3 (17)

27 (25)

0.560

  Community-acquired pneumonia

3 (17)

23 (21)

>0.999

  Healthcare-associated pneumonia

0 (0)

9 (8)

0.358

  Hospital-acquired pneumonia

0 (0)

5 (4)

>0.999

  Congestive heart failure

0 (0)

4 (3)

>0.999

  Neurologic failure

2 (11)

15 (14)

>0.999

  Other

6 (35)

31 (29)

0.777

Infection

10 (58)

67 (63)

0.788

  1. Data are n (%) or median (25th, 75th IQR), unless otherwise specified. VAP, ventilator-associated pneumonia; SAPS, simplified acute physiology score; SOFA, sequential organ failure assessment; COPD, chronic obstructive pulmonary disease; ARDS, acute respiratory distress syndrome.